Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: A randomised, double-blind, placebo-controlled, phase 2a trial

The Lancet

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2QCZXxe
via IFTTT